The best indicator for Brown & Brown (BRO)
We backtested 20 indicators across daily, weekly and hourly charts on real Brown & Brown (BRO) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Stochastic
On the daily chart, this is the strongest risk-adjusted edge we found for Brown & Brown (BRO) over ~45.3 years — trailing buy-and-hold by 4.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stochastic ✓ | Daily | 11.0% | 0.65 | -51.7% | 67.8% | 174 | -4.2% |
| 2 | Bollinger Breakout ✓ | Weekly | 9.1% | 0.62 | -42.6% | 54.8% | 42 | -6.1% |
| 3 | Rate of Change ✓ | Weekly | 10.9% | 0.62 | -48.2% | 48.6% | 138 | -4.3% |
| 4 | SMA 50/200 Cross ✓ | Daily | 12.3% | 0.59 | -48.6% | 60.0% | 30 | -3.0% |
| 5 | EMA 50/200 Cross ✓ | Daily | 12.2% | 0.58 | -43.8% | 42.9% | 28 | -3.0% |
| 6 | Donchian Midline ✓ | Weekly | 9.6% | 0.58 | -42.0% | 47.6% | 105 | -5.6% |
| 7 | Donchian Breakout ✓ | Weekly | 8.8% | 0.56 | -43.7% | 66.7% | 27 | -6.4% |
| 8 | Williams %R ✓ | Daily | 9.8% | 0.55 | -51.7% | 63.5% | 271 | -5.4% |
| 9 | ADX / DMI ✓ | Weekly | 8.9% | 0.54 | -42.7% | 53.4% | 58 | -6.2% |
| 10 | EMA 20/50 Cross ✓ | Daily | 10.0% | 0.53 | -54.2% | 46.2% | 93 | -5.3% |
| 11 | EMA 20/50 Cross ✓ | Weekly | 14.8% | 0.72 | -35.5% | 81.8% | 11 | -0.4% |
| 12 | RSI Trend (>50) ✓ | Weekly | 8.7% | 0.51 | -58.3% | 40.8% | 130 | -6.5% |
| 13 | EMA-10 Trend ✓ | Weekly | 8.4% | 0.51 | -54.1% | 48.7% | 197 | -6.8% |
| 14 | MACD ✓ | Weekly | 7.6% | 0.49 | -56.2% | 44.0% | 91 | -7.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Brown & Brown (BRO), Stochastic on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.